Announcement SK Capital Partners, LP, a well-known New York-based private investment entity focused on the life sciences, ingredients sectors and speciality materials, has declared that its syndicate has entered the deal to invest in Swixx BioPharma AG to elevate the Company’s future stage of...
Announcement Pharmanovia, a leading popular pharmaceutical company that markets the novel speciality drugs and the trusted developed medicines, has now introduced its Korjuny (Catumaxomab) in Germany. This new launch has made the T-cell connector trifunctional antibody drug the first ever and the o...
Announcement Cencora, Inc. has inked a definitive, worthy deal to acquire most of the outstanding equity interests that are not yet owned by Cencora in OneOncology’s space. The OneOncology is a physician-led commendable national platform encouraging independent medical speciality practices ba...
Announcement Immunome, Inc., a leading biotechnology company dedicated to establishing and introducing excellent, first-in-class, and best-in-class focused cancer therapies, has announced robust, positive topline results from its pivotal Phase 3 RINGSIDE trial of varegacestat, an oral, investigatio...
The first human clinical trial on proprietary probiotic strain Lactobacillus plantarum BMB1 with the Australian and New Zealand Clinical Trials registry was registered and submitted with ethics approval by Biome Australia on December 15, 2025. Initiatives: Biome Australia is partnering with La T...
With the launch of trodinetide’s formulation, Neuren has achieved its second FDA approval: In December 2025, Neuren Pharmaceuticals announced a milestone achievement with the launch of trodinetide’s formulation, partnering with Acadia Pharmaceuticals to gain U.S. FDA approval for DAYBUX...
Introduction: Ambassador MAGOSHI Masayuki has unveiled Japan’s strong step toward supporting the recovery of the health sector in Lebanon as well as underscoring the initiatives to offer the required health infrastructure for the dispensary. This reference was made during the handover ceremon...
Announcement Autobahn Labs, a leading venture studio focused on the transition of potent academic science to noteworthy business strategic drug development and exploratory programs, proudly announced that the venture has inked a deal with Astellas Pharma Inc., a global life sciences company. This ...
Announcement Mabylon AG is a known champion in the high-throughput discovery, establishment and engineering of human-inspired antibodies for the solution of inflammation, allergies and neurodegenerative diseases, has declared that its first candidate has received a dose in its first-in-human clini...
Announcement Roche, a leading multinational healthcare giant drug investigation and efforts for early stage breast cancer has finally showed progress. Roche’s oral SERD reduced death risk by 30% in early-stage breast cancer, which is a huge milestone for the company and a valuable contributi...
